Summary
Possible mechanisms by which cytosolic sodium overload may lead to the mitochondrial damage followed by ischemia/reperfusion injury were examined in perfused rat hearts. Massive accumulation of myocardial Na+ occurred, but no Ca2+ accumulation was detected during ischemia. This suggests that cytosolic sodium overload in cardiac cells may initiate ionic disturbance in the ischemia/reperfusion injury. Treatment of the pre-ischemic heart with 0.3μM tetrodotoxin, 3μM ethylisopropyl amiloride, 3μM diltiazem, or 100μM propranolol enhanced post-ischemic contractile recovery, which was associated with suppression of cellular Na+ accumulation, restoration of tissue high-energy phosphates, and preservation of the mitochondrial ability to produce ATP in the ischemic/reperfused heart. The improvement of post-ischemic contractile recovery by these agents was closely correlated with the mitochondrial ability to produce ATP at the end of ischemia. Na+ induced impairments of the mitochondrial membrane function such as attenuation of oxidative phosphorylation, swelling, depolarization of the membrane potential, release of cytochrome c in the isolated mitochondria in vitro. The Na+-induced mitochondrial impairments were not canceled under in vitro conditions by the presence of the above agents. The release of cytochrome c from the ischemic heart was observed, which was blocked by treatment of the pre-ischemic heart with these agents. The results suggest that sodium overload may induce deterioration of the mitochondrial function during ischemia and that this mitochondrial damage may determine postischemic contractile dysfunction in perfused rat hearts.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Pierce GN, Czubryt MP. 1995. The contribution of ionic imbalance to ischemia/reperfusion-induced injury. J Mol Cell Cardiol 27:53–63.
Pike MM, Luo CS, Clark MD, Kirk KA, Kitakaze M, Madden MC, Cragoe EJ Jr, Pohost GM. 1993. NMR measurements of Na+ and cellular energy in ischemic rat heart: role of Na+-H+ exchange. Am J Physiol 265:H2017–H2026.
Hendrix M, Mubagwa K, Verdonck F, Overloop K, Van Heck P, Vanstapel F, Van Lommel A, Verbeken E, Lauweryns J, Flameng W. 1994. New Na+-H+ exchange inhibitor HOE 694 improves postischemic function and high-energy phosphate resynthesis and reduces Ca2+ overload in isolated perfused rabbit heart. Circulation 89:2787–2798.
Takeo S, Tanonaka K, Hayashi M, Yamamoto K, Liu JX, Kamiyama T, Yamaguchi N, Miura A, Natsukawa T. 1995. A possible involvement of sodium channel blockade of class-I-type antiarrhythmic agents in postischemic contractile recovery of isolated perfused hearts. J Pharmacol Exp Ther 273:1403–1409.
Karmazyn M. 1991. Amiloride enhances postischemic ventricular recovery: possible role of Na+/H+ exchange. Am J Physiol 255:H608–H615.
Rubin Y, Navon G. 1993. Inhibition of sodium influx and improved preservation of rat hearts during hypothermic ischemia by furosemide and bumetanide: a 23Na- and 31P-NMR study. J Mol Cell Cardiol 25:1403–1411.
Van Emous JG, Nederhoff MGJ, Ruigrok TJC, Van Echteid CJA. 1997. The role of the Na+ channel in the accumulation of intracellular Na+ during myocardial ischemia: consequences for post-ischemic recovery. J Mol Cell Cardiol 29:85–96.
Kawada T, Yoshida Y, Sakurai H, Imai S. 1992. Myocardial Na+ during ischemia and accumulation of Ca2+ after reperfusion: a study with monensin and dichlorobenzamil. Jpn J Pharmacol 59:191–200.
Piper HM, Siegmund B, Ladilov Y, Schluter KD. 1993. Calcium and sodium control in hypoxic-reoxygenated cardiomyocytes. Basic Res Cardiol 88:471–482.
Regits V, Paulson DJ, Honach RJ, Little SE, Shaper W, Shung AG. 1984. Mitochondrial damage during myocardial ischemia. Basic Res Cardiol 79:207–217.
Piper HM, Noll T, Siegmund B. 1994. Mitochondrial function in oxygen depleted and reoxygenated myocardial cell. Cardiovasc Res 28:1–15.
Suleiman M, Halestrap AP, Griffiths EJ. 2001. Mitochondria: a target for myocardial protection. Pharmacol Ther 89:29–46.
Eng S, Maddaford TG, Kardami E, Pierce GN. 1998. Protection against myocardial ischemic/reper-fusion injury by inhibitors of two separate pathways of Na+ entry. J Mol Cell Cardiol 30:829–835.
Bugge E, Munch-Ellingsen J, Ytrehus K. 1996. Reduced infarct size in the rabbit heart in vivo by ethyhsopropyl-amiloride. A role for Na+/K+ exchange. Basic Res Cardiol 91:203–209.
Tanonaka K, Takasaki A, Kajiwara H, Takeo S. 2000. Contribution of sodium channel and sodium/hydrogen exchanger to sodium accumulation in the ischemic myocardium. Gen Pharmacol 34:167–174.
Weishaar RE, Bing RJ. 1980. The beneficial effect of a calcium channel blocker, diltiazem, on the ischemic-reperfused heart. J Mol Cell Cardiol 12:993–1009.
Takeo S, Tanonaka K, Miyake K, Fukumoto T. 1988. Role of ATP metabolites in induction of incomplete recovery of cardiac contractile force after hypoxia. Can J Cardiol 4:193–200.
Fujioka H, Yoshihara S, Tanaka T, Fukumoto T, Kuroiwa A, Tanonaka K, Hayashi M, Takeo S. 1991. Enhancement of post-hypoxic contractile and metabolic recovery of perfused rat hearts by dl-propranolol: possible involvement of non-beta-receptor mediated activity. J Mol Cell Cardiol 23:949–962.
Liu XK, Ebgelman RM, Agrawal HR, Das DK. 1991. Preservation of membrane phospholipids by propranolol, pindolol, and metoprolol: a novel mechanism of action of beta-blockers. J Mol Cell Cardiol 23:1091–1100.
Tanonaka K, Kajiwara H, Kameda H, Takasaki A, Takeo S. 1999. Relationship between myocardial cation content and injury in reperfused rat hearts treated with cation channel blockers. Eur J Pharmacol 372:37–48.
Sanbe A, Tanonaka K, Hanaoka Y, Katoh T, Takeo S. 1993. Regional energy metabolism of failing hearts following myocardial infarction. J Mol Cell Cardiol 25:995–1013.
Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. 1951. Protein measurement with the folin phenol reagent. J Biol Chem 261:6300–6306.
Takeo S, Miyake K, Tanonaka K, Takagi N, Takagi K, Kishimoto K, Suzuki M, Katsuragi A, Goto M. 1996. Beneficial effect of nebracetam on energy metabolism after microsphere-induced embolism in rat brain. Arch Int Pharmacodyn 331:232–245.
Takeo S, Tanonaka K, Tanonaka R, Miyake K, Hisayama H, Ueda N, Kawakami K, Tsumura H, Katsushika S, Tanigichi Y. 1991. Alterations in cardiac function and subcellular membrane activities after hypervitaminosis. D3. Mol Cell Biochem 107:169–183.
Kamo N, Muramatsu M, Hongoh R, Kobatake Y. 1979. Membrane potential measured with an electrode sensitive to tetraphenyl-phosphonium and relationship between proton electrochemical potential and phosphorylation potential in steady state. J Membr Biol 49:105–121.
Brierley GP, Jurkowits M, Jung DW. 1978. Osmotic swelling of heart mitochondria in acetate and chloride salts. Arch Biochem Biophys 126:276–288.
Ladilov Y, Haffner S, Balser-Schafer C, Maxeiner H, Piper HM. 1999. Cardioprotective effects of KB-R7943: a novel inhibitor of the reverse mode of Na+/Ca2+ exchanger. Am J Physiol 276: H1868–H1876.
Murphy E, Perlman M, London RE, Steenbergen C. 1991. Amiloride delays the ischemia-induced rise in cytosolic free calcium. Circ Res 68:1250–1258.
Silverman HS, Stern MD. 1994. Ionic basis of ischemic cardiac injury: insights from cellular studies. Cardiovasc Res 28:581–597.
Ju Y-K, Saint DA, Gage PW. 1996. Hypoxia increases persistent sodium current in rat ventricular myocytes. J Physiol (London) 497.2:337–347.
Ando H. 1990. Novel effect of azide on sodium channel of Xenopus oocytes. Biochem Biophys Res Commun 172:300–305.
Guc OM, Boachi-Ansah G, Kane KA, Wadworth RM. 1993. Comparison of antiarrhythmic and electrophysiologic effects of diltiazem and its analogue siratiazem. J Cardiovasc Pharmacol 22:681–686.
Cohen C-M, Gettes LS, Katzung BG. 1984. Maximal upstroke velocity as an index of available sodium conductance. Comparison of maximal upstroke velocity and voltage clamp measurements of sodium current in rabbit Purkinje fibers. Circ Res 54:636–651.
Takeo S, Yamada H, Tanonaka K, Hayashi M, Sunagawa N. 1990. Possible involvement of membrane-stabilizing action in beneficial effect of beta-adrenoceptor blocking agents on hypoxic and posthypoxic myocardium. J Pharmacol Exp Ther 254:847–856.
Neely JR, Grotyohann LW. 1984. Role of glycolytic products in damage to ischemic myocardium. Dissociation of adenosine triphosphate levels and recovery of function of reperfused ischemic heart. Cir Res 55:816–824.
Docherty JC, Kuzio B, Siivester JA, Bowes J, Thiemermann C. 1999. An inhibitor of poly (ADP-ribose) synthase activity reduces contractile dysfunction and preserves high-energy phosphate levels during reperfusion of ischaemic rat heart. Br J Pharmacol 124:1760–1766.
Liu J-X, Tanonaka K, Sanbe A, Yamamoto K, Takeo S. 1993. Beneficial effects of quinidine on post-ischemic contractile failure of isolated rat hearts. J Mol Cell Cardiol 25:1249–1263.
Nayler WG, Panagiotopoulos S, Elz JS, Daly MJ. 1988. Calcium mediated damage during postischemic reperfusion. J Mol Cell Cardiol 20(Suppl II):41–54.
Cockrell RS. 1973. Energy-linked ion translocation in submitochondrial particles.3. Transport of monovalent cations by submitochondrial particles. J Biol Chem 248:6828–6833.
Mitchell P, Mole J. 1969. Translocation of some anions cations and acids in rat liver mitochondria. Eur J Biochem 9:149–55.
Papa S, Guerrieri F, Simone S, Lorusso M, Larosa D. 1973. Mechanism of respiration-driven proton translocation in the inner mitochondrial membrane. Biochim Biophys Acta 292:20–38.
Nath S, Garlid KD. 1988. In: Integration of mitochondrial function (Lemasters JJ, Hachenbrock CR, Thurman RG, Westerhoff HV. eds.), Plenum Press, New York, pp. 357–364.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Takeo, S., Iwai, T., Tanonaka, K. (2003). Sodium Overload and Mitochondrial Damage in Ischemic/Reperfused Heart. In: Dhalla, N.S., Takeda, N., Singh, M., Lukas, A. (eds) Myocardial Ischemia and Preconditioning. Progress in Experimental Cardiology, vol 6. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0355-2_4
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0355-2_4
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-5036-1
Online ISBN: 978-1-4615-0355-2
eBook Packages: Springer Book Archive